| Literature DB >> 36161185 |
Tingting Wang1, Duanhua Cao1, Jingzhe Han1.
Abstract
Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) is an uncommon ocular motility disorder that encompasses the following clinical signs: bilateral adduction deficits, bilateral abducting nystagmus, convergence lost, and a large angle exotropia in primary gaze. Here we report a case of a 55-year-old man presenting with atypical WEBINO syndrome with unilateral exotropia. The coverage test was used to record the patient's alternating exotropia. The patient experienced diplopia and ophthalmoplegia and was admitted to our hospital 3 days after the onset of the double vision. Neurologic examination showed left eye exotropia and bilateral internuclear ophthalmoplegia with impaired convergence. Vertical saccades of the left eye were also limited. Consequently, an MRI scan suggested an acute infarction in the left of the pontine tegmentum. The patient was finally diagnosed with pons infarction and was treated with anticoagulation and anti-platelet aggregation therapy.Entities:
Keywords: case; infarction; magnetic resonance imaging; pons; wall-eyed internuclear ophthalmoplegia acute infarction
Year: 2022 PMID: 36161185 PMCID: PMC9500521 DOI: 10.3389/fnins.2022.974645
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 5.152
Figure 1Brain MRI: Diffusion-weighted images reveal a focal ischemic stroke in the dorsal pons (arrows).
Analysis of clinical data of WEBINO patients.
|
|
|
|
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| ||||||
| 1. Inocencio and Ballecer ( | 1 | 24 | M | Y | Y | Y | N | N | N | N | N | CNS MTI | Mid, Pons |
| 2. Lana et al. ( | 1 | 35 | F | Y | Y | Y | N | N | N | N | N | CNS vasculitis | – |
| 3. Fay and Strominger ( | 1 | 33 | M | Y | Y | Y | N | N | N | N | N | CNS Cry | Mid |
| 4. Korkmaz et al. ( | 1 | 14 | F | Y | Y | N | N | N | N | N | N | CIDP | – |
| 5. Ozer et al. ( | 1 | 15 | M | Y | – | – | – | – | – | Y | N | DAD | Mid, Pons |
| 6. Chen and Lin ( | 4 | 66 | M | Y | Y | N | N | Y | N | N | N | CI | Mid |
| 84 | M | Y | Y | N | N | Y | N | N | N | CI | Mid, Pons | ||
| 51 | F | Y | Y | N | N | N | N | N | N | Hyd, brainstem neoplasms | Mid, Pons | ||
| 65 | F | Y | Y | Y | N | N | N | N | N | CI | Pons | ||
| 7. Kim et al. ( | 1 | 78 | M | Y | Y | Y | N | Y | N | N | N | CI | Mid |
| 8. Matsumoto et al. ( | 1 | 72 | M | Y | Y | Y | N | Y | N | N | N | PSP | Mid |
| 9. Ushio et al. ( | 1 | 72 | M | Y | Y | Y | N | Y | N | N | N | PSP | Mid |
| 10. Jacob et al. ( | 1 | 67 | M | Y | – | – | – | – | N | N | N | Hyd, SAH | – |
| 11. Sierra-Hidalgo et al. ( | 1 | 55 | F | Y | Y | N | Y | Y | N | Y | N | CI | Mid |
| 12. Shinoda et al. ( | 1 | 19 | F | Y | Y | N | N | N | N | Y | N | NMOSD | Mid |
| 13. Beh and Frohman ( | 1 | 69 | M | Y | Y | Y | N | Y | N | N | N | CI | Mid, Pons |
| 14. Jadhav and Prasad ( | 1 | 41 | M | Y | Y | N | N | N | Y | N | N | Hyd, CM | – |
| 15. Sakamoto et al. ( | 1 | 64 | M | Y | Y | Y | N | N | N | N | N | CI | Pons |
| 16. Bar et al. ( | 1 | 12 | F | Y | Y | N | N | Y | Y | N | N | Dem | Mid |
| 17. Chakravarthi et al. ( | 1 | 64 | F | Y | Y | Y | N | Y | N | N | N | CI | Mid |
| 18. Mathis et al. ( | 1 | 68 | M | Y | Y | Y | N | N | N | N | N | CI | Pons |
| 19. Muralidhar et al. ( | 1 | 35 | M | Y | Y | N | N | N | N | N | N | Alcohol | - |
| 20. Nakajima et al. ( | 1 | 68 | M | Y | Y | Y | Y | Y | N | N | N | CI | Mid, Pons |
| 21. de Mora et al. ( | 1 | 57 | M | Y | Y | Y | N | N | Y | N | N | CI, Neurosyphilis | Mid |
| 22. Toufeeq and Dave ( | 1 | 13 | M | Y | Y | Y | N | Y | Y | Y | N | Pineal tumor | Mid |
| 23. Agarwal et al. ( | 1 | 19 | F | Y | Y | Y | N | Y | Y | N | Y | CI | Mid, Pons |
| 24. Ljevak et al. ( | 1 | 53 | M | Y | Y | N | Y | Y | N | Y | Y | CI | Mid |
| 25. Man et al. ( | 1 | 84 | M | Y | Y | Y | N | Y | N | N | N | CI | Mid |
| 26. de Souza et al. ( | 1 | 60 | F | Y | Y | Y | N | Y | N | Y | N | PSP | Mid |
| 27. Sajjadi et al. ( | 1 | 38 | M | Y | Y | Y | N | N | N | N | N | – | – |
| 28. Zou and Chen, | 1 | 70 | F | Y | Y | Y | Y | Y | N | N | N | NMOSD | Mid |
| 29. Papageorgiou et al. ( | 1 | 65 | M | Y | Y | N | N | N | N | N | N | CI | Mid |
| 30. Keereman et al. ( | 1 | 25 | F | Y | Y | N | Y | N | N | Y | N | Hyd | – |
| 31. Matsumoto et al. ( | 1 | 81 | M | N | Y | Y | N | Y | N | N | N | PSP | Mid |
| 32. Yazdi et al. ( | 1 | 57 | M | Y | Y | Y | N | Y | N | N | N | PSP | Mid, Pons |
| 33. Vázquez-Justes et al. ( | 1 | 68 | M | N | Y | N | N | N | N | N | N | Ischemic lesion | Mid |
| 34. Im et al. ( | 1 | 62 | F | N | Y | N | N | N | N | N | N | Stroke | Pons |
| 35. Petrik et al. ( | 1 | 55 | M | Y | N | N | N | N | N | N | N | CH | Pons |
| 36. Jo et al. ( | 1 | – | – | – | – | – | – | – | – | – | – | CI | Mid |
| 37. Sinha et al. ( | 1 | 48 | F | N | Y | N | Y | N | Y | Y | N | CH | Brainstem |
| 38. Ansari et al. ( | 1 | 45 | F | Y | Y | N | N | N | N | N | N | irEA | – |
| 39. Wako et al. ( | 1 | 85 | M | Y | Y | Y | N | N | N | N | N | CES | Mid, Pons, Cer |
Aa, Exotropia in the first eye-position; Bb, Bilateral Intraocular Disorders; Cc, Convergence barrier; Dd, Blepharoptosis; Ee, Vertical gaze disorder; Ff, Vertical nystagmus; Gg, Pupillary anomalies; Hh, Reversed dip. M, Male; F, Female; Y, yes; N, No; CI, Cerebral infarction; CH, Cerebral hemorrhage; Mid, Midbrain; Cer, cerebellum; Cry, Cryptococcosis infection; MTI, Mycobacterium tuberculosis infection; CNS, Central nervous system; CIDP, Chronic inflammatory demyelinating polyradiculoneuropathy; Hyd, Hydrocephalus; DAD, Diffuse axonal damage; PSP, Progressive superanuclear palsy; CES, cardioembolic stroke; SAH, Subarachnoid hemorrhage; NMOSD, Neuromyelitis optica spectrum disorders; CM, Cryptococcal meningitis; Dem, Demyelinating Diseases; irEA, Immune related adverse event.